<Japanese >>Oct.9(Tue)
>>Oct.10(Wed)
>>Oct.11(Thu)
  (update 2018.9.9)  
Oct.9(Tue) Oct.9(Tue) Oct.9(Tue)
Oct
9



1st
day
Time 1F 2F 3F 5F 4F
Hall Fukuju(144) Togen(144) Heian Zuiun 303 Small Hall(250) Training Room(84) 401(63) 402(30) 403(30) 406(30) 407(36)
10:00-10:20   <Opening Remarks>                    
10:20-11:00   <Conference Chairperson>
Chair: Shinichi Katakura(DAIICHI SANKYO RD NOVARE CO., LTD.)
K-01 Masahiro Nishijima (Director Emeritus of National Institute of Health Sciences, NIHS)
"What is Regulatory Science?"
                   
11:00-12:00   <Plenary Lecture> "Strategic Utilization of Arificial Inteligence to Drug Discovery"
Chair: Akihiko Konagaya (Tokyo Institute of Technology)
K-02 Kenji Mizuguchi (National Institutes of Biomedical Innovation, Health and Nutrition)
"The status of AI development in the Life Intelligence Consortium (LINC)"
K-03 Kazuki Iwamoto (Fujitsu Limited)
"Pathological Recognition by Artificial Intelligence" Taro Kiritani (ExaWizards Inc.)
"Prediction of Compound-Protein Interaction Using the Graph Convolutional Network "
Koichiro Kato (Mizuho Information & Research Institute, Inc.), Tomohide Masuda (Toray Industries, Inc.)
"Toward A High-Accuracy Molecular Force Field Using Machine Learning "
                   
12:00-13:30             <Luncheon Seminar>
LS-01 MOLSIS Inc.
<Luncheon Seminar>
LS-02 Arxspan LLC
       
13:30-14:00 Poster Session                      
14:00-15:30   <Invited Talk> "Safety Prediction and Management in Drug Seed Investigation"
Chair: Hiroshi Suzuki (The Univ. of Tokyo Hospital)
I-01 Yasunari Kanda (National Institute of Health Sciences, NIHS)
"Development of a new testing method using iPS cell technology and international standardization strategy"
I-02 Yoshihiro Uesawa (Meiji Pharmaceutical Univ.)
"A strategy for toxicity prediction based on artificial intelligence"
I-03 Akihiro Hisaka (Chiba Univ.)
"Use of Markov Chain Monte Carlo Method in Pharmacokinetic Analysis"
<Invited Talk>
"Role of QM calculation in in silico drug discovery" 
Chair: Kaori Fukuzawa(Hoshi University)
I-04
 Alexander Heifetz
(Evotec UK)
"FMO guided drug discovery and structural analysis"
I-05
Hiroaki Tokiwa
(Rikkyo University)
"Elucidating the efficacy of clinical drugs using the first-principles calculations"
I-06
Suyong Re
(RIKEN)
"Prediction of protein-ligand binding affinity from dynamic docking"
<Focused Session>
FS-01
The 2nd About principles of OMICs “What is the principle of "life" and biodiversity?”
<Sponsor's workshop>
Biospire Japan Ltd./Lifematics Inc.
"Innovative drug discovery platform combining next generation GPU simulation and disease modelled iPS cells."
Giovanna Tedesco (Cresset), Sunhwan Jo (SilcsBio), Marcus Yeo (DefiniGEN)
<The 2nd International Conference on Molecular Robot Ethics>
Special Interest Group of Molecular Robot Ethics, Japan Science and Technology Agency, Human Information Technology Ecosystem

Chair:Ryuma Shineha (Seijo University)

"Molecular Robotics, ELSI and TA session"
Akihiko Konagaya(Tokyo Institute of Technology)
"Molecular Robotics: Is Concept, Technology and Ethics"
Daisuke Kiga (Waseda University)
"Safety engineering by synthetic biology
Erika Szymanski (The University of Edinburgh)
“Designing RRI after ELSI: To whom are we responsible?”
<Focused Session>
FS-02
Oral Presentation
(AI for drug discovery and medical treatment)
<Focused Session>
FS-03
Computational Toxicology - Basic Techniques (Chemometrics, QSAR, metabolomics)

<Focused Session>
FS-04
A new challenge to individualized medicine for cancer therapy
   
15:30-16:00 Poster Session                      
16:00-17:30   <Sponsored Session>
SS-01
Japan Agency for Medical Research and Development
<Focused Session>
FS-06
Toward overcoming neurodegenerative diseases: approach of computational science and structural biology
    <The 2nd International Conference on Molecular Robot Ethics>
Special Interest Group of Molecular Robot Ethics, Japan Science and Technology Agency, Human Information Technology Ecosystem

"Interdisciplinary Technology Assessment session"

Naoto Kawahara (Kyushu University)
"Japanese Perspectives on Molecular Robotics: Formulating Ethical Principles of Molecular Robotics (ver. 1.1)"
Kenneth Oye (MIT Political Science, USA)
"On governing risks of emerging technologies: Exemplary cases and cautionary tales from synthetic biology"
Stephan Lingner(EA European Academy of Technology and Innovation Assessment, Germany)
"Interdisciplinary technology assessment – practice and outlook for responsible molecular robotics"
<Focused Session>
FS-07
Oral Presentation
(In silico drug discovery)
<Focused Session>
FS-08
Computational toxicology - practical and application
      <Focused Session>
FS-09
Invitation to Stem Cell-based Chemical Risk Information Consortium (scChemRISC)
17:30-19:30 Poster Session                      
 >>page top
 
>>page top  
Oct.10(Wed) Oct.10(Wed) Oct.10(Wed)
Oct
10
Wed

2nd
day
Time 1F 2F 3F 5F 4F
Hall Fukuju Togen Heian Zuiun 303 Small Hall Training Room 401 402 403 406 407
10:00-11:30   <Plenary Lecture> "Bio-Bank as Drug Discovery and Drug Lifecycle Management Resources"
Chair: Soichi Ogishima (Tohoku Medical Megabank Organization, Tohoku Univ.)
K-04 Hiroshi Nishihara (Keio Univ.)
"On-Demand type biobanking will promote drug discovery in Japan"
K-05 Hiroshi Tanaka (Tokyo Medical and Dental Univ. /Tohoku Medical Megabank Organization)
"Clinical Research based on real world data in the era of precision medicine"

                   
11:30-13:00             <Luncheon Seminar>
LS-03
 Dotmatics Ltd
<Luncheon Seminar>
LS-04 Patcore, Inc.
  12:00-13:00
CBI Meeting of the Board of Councilors
  <Luncheon Seminar>
LS-07 CBI general meeting
13:00-14:00 Poster Session                      
14:00-15:30   <Invited Talk> "Bio-Bank as Drug Discovery and Drug Lifecycle Management Resources"
Chair: Seiichi Ishida (National Institute of Health Sciences, NIHS)
I-07 Koichi Kawakami (National Institute of Genetics, NIG)
"An new era of disease modeling and drug screening with zebrafish"
I-08 Kim Yun-Gi (Keio Univ. Faculty of Pharmacy)
"Gut bugs as drugs"
I-09 Norimasa Miyamoto (Eisai Co., Ltd.)
"Toward the development of assessment methodology for seizure phenotypes using human iPSC-derived neurons"

<Symposium>
Development of in vitro human body/tissue-mimicing model using high functional cell devices - The challenge to global competition based on collaboration between industry, government and academia in Japan-
<Focused Session>
FS-10
Chemical data science" by artificial intelligence and big data Development to Computational toxicology, Drug discovery, Property evaluation and others (1)
  <Symposium>
Research activities for supporting drug discovery by in-silico unit of BINDS (AMED)
<Focused Session>
FS-11
Oral Presentation
(Molecular recognition and molecular modeling)
<Focused Session>
FS-12
In silico ADME-TOX / Current Status and Issues for Drug Discovery - Efforts in pharmaceutical companies -
<Sponsor's workshop>
Biomodeling Research Co., Ltd.
    <Focused Session>
FS-13
Advanced Measurement and Analysis
15:30-16:00 Poster Session                      
16:00-17:30   <Sponsored Session>
SS-02
Japan Agency for Medical Research and Development
"Active Utilization of Biobanks and its Ethical, Legal and Social Issues (ELSI)"
<Symposium> <Symposium>
"AI-Substances Hazardous Integrated Prediction System (AI-SHIPS) Project"
  <Symposium>
Research activities for supporting drug discovery by in-silico unit of BINDS (AMED)
<Focused Session>
FS-14
Oral Presentation
(Bioinformatics and its applications in medicine)
<Focused Session>
FS-15
Beyond the Pills - the Right Drug, Right Dose, Right Time

  <Focused Session>
FS-16
Origin of Life: Its Current Status and Perspective
<Focused Session>
FS-13
Advanced Measurement and Analysis
17:30-19:00 Poster Session                      
19:00-21:00     Banquet                  
 >>page top
 
>>page top  
Oct.11(Thu) Oct.11(Thu) Oct.11(Thu)
Oct
11
Thu

3rd
day
Time 1F 2F 3F 5F 4F
Hall Fukuju Togen Heian Zuiun 303 Small Hall Training Room 401 402 403 406 407
10:00-12:00   <Plenary Lecture> "Utilization of Adverse Effect Information in Drug Lifecylcle Management"
Chair: Takashi Mizuma (Teikyo Heisei Univ.)
K-06 Yasufumi Sawada (The Univ. of Tokyo)
"Information of adverse drug event in drug lifetime management (ikuyaku)"
K-07 Yoshiaki Uyama (Pharmaceuticals and Medical Devices Agency, PMDA)
"Real world data-based drug safety assessment in the era of global simultaneous approval"
                   
12:00-13:30             <Luncheon Seminar>
LS-05 GDEP ADVANCE,Inc.
<Luncheon Seminar>
LS-06 Special Interest Group of Molecular Robot Ethics
"Is molecular robotics a friend or foe of the human being?"
       
13:30-14:00 Poster Session   <Sponsored Session>
SS-03
TSUMURA & CO.
 
  <Public Lecture>
"Facing the dementia age"
Keiko Nakano (Professor of “Wa-Kan-Zen”)
"“Yakuzen” is a familiar approach to our healthcare"
Michiya Igase (Ehime University Graduate School of Medicine)
"Auraptene in the Peels of Citrus Kawachiensis (Kawachibankan) Contributes to the Preservation of Cognitive Function: A Randomized, Placebo-Controlled, Double-Blind Study in Healthy Volunteers "
Kanako Watanabe (Koto Plan Association)
14:00-15:30   <Panel discussion>
"Regulatory Sciences in the AI-driven Drug Discovery Age"
Chair: Yasunari Kanda (National Institute of Health Sciences, NIHS)
Panelist:
Teruki Honma (RIKEN)
Shinichi Katakura (DAIICHI SANKYO RD NOVARE CO., LTD.)
Hiroshi Tanaka (Tokyo Medical and Dental Univ. /Tohoku Medical Megabank Organization)
Masahiro Nishijima (Director Emeritus of National Institute of Health Sciences, NIHS)
Yoshiaki Uyama (Pharmaceuticals and Medical Devices Agency, PMDA)

    <Focused Session>
FS-17
Oral Presentation
(Information and computational approach for drug design and ADMET study) / (Regulatory Sciences)
<Focused Session>
FS-18
Oral Presentation
(Emerging new technology)
     
15:30-16:00   <Poster Award>                    
16:00-16:10   <Closing Remarks>                    
>>page top >>page top

> <
> <